Navigating the complexities of drug development for inflammatory bowel disease

S Honap, V Jairath, S Danese… - Nature Reviews Drug …, 2024 - nature.com
Inflammatory bowel disease (IBD)—consisting of ulcerative colitis and Crohn's disease—is a
complex, heterogeneous, immune-mediated inflammatory condition with a multifactorial …

The use of linked administrative data in Australian randomised controlled trials: A scoping review

S Fahridin, N Agarwal, K Bracken, S Law… - Clinical …, 2024 - journals.sagepub.com
Background/Aims: The demand for simplified data collection within trials to increase
efficiency and reduce costs has led to broader interest in repurposing routinely collected …

[HTML][HTML] Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage

AM Toader, MK Campbell, JK Quint, M Robling… - Trials, 2024 - Springer
Background Healthcare system data (HSD) are increasingly used in clinical trials,
augmenting or replacing traditional methods of collecting outcome data. This study …

[HTML][HTML] Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials

MR Sydes, ML Murray, S Ahmed, S Apostolidou… - Contemporary Clinical …, 2024 - Elsevier
Background Better use of healthcare systems data, collected as part of interactions between
patients and the healthcare system, could transform planning and conduct of randomised …

[HTML][HTML] The use of healthcare systems data for RCTs

AM Toader, CL Gamble, S Dodd, PR Williamson - Trials, 2024 - Springer
Background Healthcare systems data (HSD) has the potential to optimise the efficiency of
randomised controlled trials (RCTs), by decreasing trial-specific data demands. Therefore …